Fresenius Medical Care Deutschland GmbH | Date: 2016-11-21
A device and a method are provided for blood treatment in a single-needle operating mode. The blood treatment device has an extracorporeal blood circuit comprising a blood supply line leading to the inlet of a blood treatment unit and a blood return line leading away from the outlet of the blood treatment unit. A blood collecting container is provided in the blood return line, and is connected to an air reservoir by a flow line. The flow connection comprises two line branches, one branch being used to transfer gas from the air reservoir into the blood collecting container and the other branch being used to transfer gas from the blood collecting container into the air reservoir. The connection branch for transferring gas from the air store into the blood collecting container can contain a compressor.
Fresenius Medical Care Deutschland GmbH | Date: 2016-08-29
A network-based electronic therapy monitoring system includes: at least one database server configured for storing patient data and therapy data, wherein the database server is arranged within a protected subnet of a data transfer network, the protected subnet being protected by a firewall; at least one server arranged in the data transfer network outside of the protected subnet; and at least one client assigned to a therapy device and/or to a patient, wherein the at least one client is also arranged outside the protected subnet; wherein the at least one client is configured to push therapy data and/or patient data to the at least one server; and wherein the at least one database server is configured to pull therapy data and/or patient data from the at least one server.
Fresenius Medical Care Deutschland GmbH | Date: 2017-01-18
The invention relates to a blood treatment cartridge (1000) with a cartridge body, which is designed as a hard part (1), and a film (3). The film (3) is connected to the hard part (1), and the hard part (1) is at least partly covered. The hard part (1) has at least one valve base (226) of a valve (288), and the valve (288) is designed to assume a second closed valve (288) position, in which the valve base (226) and a valve (3) section arranged over the valve base contact each other, in addition to a first open valve (288) position, in which the valve base (226) and the film (3) section do not contact each other, by applying a force onto the film (3) section.
Fresenius Medical Care Deutschland GmbH | Date: 2016-01-06
The present application shows a container for preparation of a peritoneal dialysis solution, the container comprising a first compartment containing a first solution comprising sodium ions and at least a second compartment containing a second solution comprising glucose, wherein mixing of the first solution with the at least second solution results in a final solution comprising sodium ions in a concentration of 100 to 115 mM, glucose in a concentration of 1% to 5% by weight, and a low level of glucose degradation products.
Fresenius Medical Care Deutschland GmbH | Date: 2016-08-22
The invention relates to a method and a device for monitoring a vascular access during an extracorporeal blood treatment. The method and the device according to the invention are based on the monitoring of the difference between the venous pressure measured by a venous pressure sensor and the arterial pressure measured by an arterial pressure sensor (in the extracorporeal blood circuit. According to the method and the device according to the invention, a test function describing disturbances in the extracorporeal blood circuit is determined. Said test function is used to determine a noise-free differential pressure from the measured venous and arterial pressure, said differential pressure being evaluated in an arithmetic and evaluation unit to identify a defective vascular access.
Fresenius Medical Care Holdings Inc. and Fresenius Medical Care Deutschland GmbH | Date: 2016-08-08
This disclosure relates to methods of reversing blood flow using a blood flow reversal valve that includes a first member having a first passage and a second passage, and a second member having a first passage and a second passage. The first and second members are rotatably fixed relative to one another such that the first passage of the first member is aligned with the first passage of the second member and the second passage of the first member is aligned with the second passage of the second member. A flow directing element is disposed in the cavity and is moveable relative to the first and second members between a first position in which the first passage of the first member and the first passage of the second member are fluidly connected and a second position in which the first passage of the first member and the second passage of the second member are fluidly connected.
Fresenius Medical Care Deutschland GmbH | Date: 2016-06-15
This document relates to bi-carbonate-buffered dialysis solutions with physiological phosphate content and increased stability. The solutions include an organic ester of phosphoric acid, calcium ions and/or magnesium ions, and optionally additional electrolytes, buffers and glucose in physiologically effective concentrations.
Fresenius Medical Care Deutschland GmbH | Date: 2016-06-07
The present invention relates to a dialysis solution having at least one osmotic agent, wherein the osmotic agent is starch propylphosphonate.
Fresenius Medical Care Deutschland GmbH | Date: 2016-03-23
It is described a point-of-use (POU) water purifier (10), comprising a housing (11) the inner space of which is divided by a bundle (16) of hollow fibers into an inlet compartment (14) in fluid communication with an opening (12) for connection of the purifier to the waterworks, and an outlet compartment (15) in fluid communication with the outlet (13) of purified water; the hollow fibers have an inner diameter between 150 and 250 m and a wall thickness between 30 and 50 m, and have pores of different size and shape on the inner and outer surface of the fiber.
Fresenius Medical Care Deutschland GmbH | Date: 2016-02-01
A device and method for detecting recirculation for an extracorporeal blood treatment apparatus and an apparatus with a device for detecting recirculation are based on targeted haemodilution by administration of a substituate bolus, causing a pressure change in venous and arterial branches of the extracorporeal circuit due to a viscosity change of flowing fluid. Recirculation is detected based on detection of the pressure change. The device includes a control unit cooperating with a device for conveying blood and a device for supplying substituate. The control unit provides an operating mode for detecting recirculation, in which blood flow rate is reduced during administration of a substituate bolus. With simultaneous substituate bolus administration and reduction of blood flow rate, the composition of fluid flow is optimised for detection of recirculation, so that fairly large pressure changes result in venous and arterial branches, thereby improving sensitivity and reliability of the measurement method.